HempNewsBreaks – Singlepoint, Inc. (SING) Comments on Proposed Congressional Legislation to Regulate Marijuana

In March, Congress introduced legislation to regulate and tax marijuana, and to remove it from the federal Controlled Substances Act. SinglePoint, Inc. (OTC: SING) CEO Greg Lambrecht recently commented on how the proposed legislation could affect the company. SinglePoint has seen much revenue potential in the realm of legal cannabis, and hopes measures will be taken to streamline federal and state oversight of the market. Its interests go beyond investing. The congressional push should also help boost the value of its SingleSeed (www.SingleSeed.com) payments solutions for businesses in the cannabis industry. ‘For the near term, the best way the administration can help would be to issue guidelines on how the cannabis business can be successfully banked,” said Lambrecht.

To view the full article, visit http://nnw.fm/XKtY6

About SinglePoint, Inc.

SinglePoint, Inc. is a full-service mobile technology and marketing provider. The company provides solutions that allow its clients to conduct business transactions, accept donations, and engage in targeted communication through mobile devices. SinglePoint’s products connect small to mid-size companies to their target markets by providing innovative mobile technology at reasonable rates. Additionally, the company recognized the strength in acquiring interest in undervalued subsidiaries in other markets to create a diversified holding base. For more information visit www.SinglePoint.com.

About NetworkNewsBreak

NetworkNewsBreak (NNB) provides a rapid summary of corporate news that caught the attention of HempWire (HW). NNB keeps you up-to-date on active US Public Companies complementary to HW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

Please see full disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, CO
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

Chris@HW

Share
Published by
Chris@HW

Recent Posts

HempNewsBreaks – Turning Point Brands Inc. (NYSE: TPB) Closes $300M Senior Secured Notes Offering 

Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…

2 months ago

HempNewsBreaks – WEED Inc. (BUDZ) Announces 2024 Highlights, Plans to Expand into Consumer Packaged Goods

WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…

4 months ago

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct

Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…

4 months ago

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to Host Spaces Event, Share Comprehensive Update on Destino Ranch

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced its plans to host a Spaces call…

5 months ago

HempNewsBreaks – CBD Life Sciences Inc. (CBDL) Poised to Become Game Changer in the Hemp Industry

CBD Life Sciences (OTC: CBDL) today announced its potential for explosive profits in a $70…

6 months ago

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that…

7 months ago